NCT03261050View on ClinicalTrials.gov

Target Engagement of a Novel Dissonance-Based Treatment for DSM-5 Eating Disorders

NACompletedINTERVENTIONAL
Enrollment

83

Participants

Timeline

Start Date

July 10, 2017

Primary Completion Date

January 24, 2025

Study Completion Date

January 31, 2025

Conditions
Eating Disorder
Interventions
BEHAVIORAL

Counter Attitudinal Therapy

8 weekly 60 minute sessions of dissonance-based treatment wherein women with any eating disorder complete verbal, written, and behavioral activities.

BEHAVIORAL

Interpersonal Therapy

8 weekly 60 minute sessions of interpersonal-based treatment wherein women with an eating disorder complete verbal, written, and behavioral activities.

Trial Locations (2)

94305

Stanford University, Stanford

97403

Oregon Research Institute, Eugene

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

Stanford University

OTHER

NCT03261050 - Target Engagement of a Novel Dissonance-Based Treatment for DSM-5 Eating Disorders | Biotech Hunter | Biotech Hunter